Loading...
NPI 1447347166 · Denver, CO · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Urology Surgery Center Of Colorado LLC is a ambulatory surgical clinic/center provider located in Denver, Colorado. This profile covers 24 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Urology Surgery Center Of Colorado LLC |
| Address | 2777 Mile High Stadium Cir |
| City | Denver |
| State | CO |
| ZIP | 80211 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | October 6, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.6M |
| Medicaid | $138K |
UROLOGY SURGERY CENTER OF COLORADO LLC appears to operate as an ambulatory surgical clinic with a strong focus on endoscopic urology and device-based pelvic procedures: its Medicare and Medicaid mixes are dominated by cystourethroscopy/ureteroscopy codes (52000, 52356, 52310) and it also reports meaningful revenue from neurostimulator-related codes (64590, 64561). The code mix (diagnostic and therapeutic cystoscopy, ureteroscopy with lithotripsy and stent placement, and sacral/neuromodulation implants) is consistent with an ASC that handles high-throughput outpatient urologic procedures and selective implant cases.
Medicare revenue is concentrated: total Medicare revenue is $1.6M and the provider’s top three Medicare codes account for 43.2% of that Medicare revenue. Those three codes—64590 ($271.4K, 17.4%), 52000 ($221.6K, 14.2%), and 64561 ($182.6K, 11.7%)—drive a large share of Medicare dollars, indicating revenue dependence on a small set of procedures.
Medicaid revenue is even more concentrated: total Medicaid revenue is $138K and the top three Medicaid codes account for 100.0% of Medicaid revenue. In practice Medicaid receipts are dominated by 52000 ($116.3K, 84.1%) and 52310 ($22K, 15.9%), showing that Medicaid activity is almost entirely diagnostic/therapeutic cystoscopy and related removals/interventions.
Payer mix is heavily Medicare-weighted: Medicare revenue of $1.6M materially exceeds Medicaid revenue of $138K, indicating Medicare is the primary commercial payer exposure for this facility. While the center bills both payers, the absolute scale of Medicare receipts suggests strategic and reimbursement sensitivity will be driven by Medicare policy and utilization trends.
For cystoscopic and stone-management services the center is a high-volume outlier: 52000 ranks #16 of 8548 providers nationally (100th percentile; extreme outlier), 52356 ranks #21 of 3090 (99th percentile; extreme outlier), and 52310 ranks #14 of 2547 (99th percentile; extreme outlier). These national percentiles imply the center is a major provider of diagnostic/therapeutic cystoscopy and ureteroscopy/lithotripsy relative to peers, consistent with drawing a steady procedural caseload or referral stream for endoscopic urology.
By contrast, the facility’s device-implant work is more modest relative to national peers: 64590 ranks #221 of 561 (57th percentile; typical, unremarkable volume) and 64561 ranks #119 of 564 (79th percentile; typical, unremarkable volume). Although these codes produce high per-claim payments, the provider’s rank/percentile positions suggest implants are a complementary service line rather than the dominant business line.
Operational data point to high throughput of lower-reimbursed encounters: 52000 appears with large claim counts on both payers (1.1K Medicare claims and 1.4K Medicaid claims) and J0585 shows 5.4K claims but only $27K in Medicare revenue, indicating frequent, low-dollar-unit encounters (likely office/injection visits) alongside the higher-acuity endoscopic procedures. This mix indicates an operational model balancing many short, billable encounters with less frequent, higher-reimbursement procedures.
The practice is well-established—NPI enumerated 2006-10-06 (~20 years ago)—which supports stability and likely local market recognition. That said, the combination of long tenure and concentrated revenue in a few high-volume cystoscopy/stone codes also creates exposure: any payer policy or utilization changes affecting those high-volume codes could materially impact facility revenue given the noted concentration.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
24 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 20 | $15,080 | $271.4K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1,080 | $210 | $221.6K |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 50 | $3,890 | $182.6K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 90 | $1,650 | $145.3K |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 30 | $5,630 | $140.8K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 150 | $660 | $98.4K |
| 52601 | During transurethral resection of the prostate (TURP), the surgeon inserts a resectoscope via the urethra and removes a portion of the prostate. This procedure includes several other urological… | 40 | $1,760 | $77.2K |
| 52332 | The provider performs cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 70 | $860 | $63.3K |
| 52234 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 40 | $1,140 | $46.7K |
| 55700 | Code deleted December 31, 2025. | 60 | $650 | $40.7K |
Showing 1–10 of 24
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
24 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C9740 | 4 | 10 | 30 | $5,440 | $157.9K |
| 64590 | 7 | 20 | 20 | $6,130 | $110.4K |
| J0585 | 66 | 100 | 7,900 | $1 | $73.7K |
| 64561 | 4 | 20 | 30 | $2,090 | $69.1K |
| 52353 | 1 | 10 | 20 | $1,740 | $29.7K |
| 52648 | 8 | 10 | 20 | $1,210 | $27.8K |
| 52234 | 1 | 10 | 20 | $840 | $21.8K |
| 52601 | 2 | 30 | 20 | $970 | $18.5K |
| 50590 | 3 | 20 | 20 | $740 | $18.4K |
| 52356 | 1 | 50 | 20 | $790 | $16.5K |
Showing 1–10 of 24
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1,420 | $80 | $116.3K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 90 | $240 | $22K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 60 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Colorado providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Colorado median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1 | 10 | 190 | $140 | $49.7K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 1 | 10 | 50 | $250 | $12.6K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 19 | 30 | 70 | $0 | $0 |
Other providers in the same ZIP code as Urology Surgery Center Of Colorado LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Denver Health And Hospital Authority | CO | Federally Qualified Health Center (FQHC) | $0 | $9.1M |
| Statlab Diagnostics, LLC | CO | Clinical Medical Laboratory | $100.2K | $2.6M |
| Cher, LLC | CO | Diagnostic Radiology Physician | $214.9K | $1.7M |
| Thomas Pugh | CO | Radiation Oncology Physician | $914.7K | $0 |
| Brian Smith | CO | Urology Physician | $217.1K | $0 |
| Stephen Ruyle | CO | Urology Physician | $214K | $0 |
| Julien Dagenais | CO | Urology Physician | $116.8K | $0 |
| Lauren Abrams | CO | Urology Physician | $107.2K | $0 |
| Daniel Kaufman | CO | Urology Physician | $103.2K | $0 |
| Elias Hsu | CO | Urology Physician | $92.4K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.